Application of 1H MR spectroscopic imaging in radiation oncology: Choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors;Einsatz der 1H-MR-spektroskopischen bildgebung in der strahlentherapie: Cholin als marker für die bestimmung der relativen wahrscheinlichkeit eines tumorprogresses nach bestrahlung glialer hirntumoren

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 178, Issue 6, 2006, Pages 627-633

  Lichy, Matthias Philipp ^a,b   Bachert, P ^b   Hamprecht, F ^c   Weber, M A ^b   Debus, J ^c   Schulz Ertner, D ^c   Schlemmer, H P ^a,b   Kauczor, H U ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Brain tumors; Follow up control; Glioma; Proton MR spectroscopy; Treatment planning

Indexed keywords

CHOLINE; CREATINE PHOSPHATE; N ACETYLASPARTIC ACID; ASPARTIC ACID; CONTRAST MEDIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GADOLINIUM PENTETATE; N-ACETYLASPARTATE;

ARTICLE; BRAIN TUMOR; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE MARKER; FOLLOW UP; GLIOMA; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONCOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROBABILITY; PROTON NUCLEAR MAGNETIC RESONANCE; RADIODIAGNOSIS; SENSITIVITY AND SPECIFICITY; SIGNAL DETECTION; STEREOTAXIC SURGERY; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE; TUMOR GROWTH; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; ASTROCYTOMA; BRAIN; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; GLIOBLASTOMA; IMAGE PROCESSING; MALE; METABOLISM; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PATHOLOGY; PREDICTION AND FORECASTING; RADIATION EXPOSURE; REFERENCE VALUE; SKULL IRRADIATION; TUMOR RECURRENCE;

ADULT; ASPARTIC ACID; ASTROCYTOMA; BRAIN; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHOLINE; COMBINED MODALITY THERAPY; CONTRAST MEDIA; CRANIAL IRRADIATION; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM DTPA; GLIOBLASTOMA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; OLIGODENDROGLIOMA; PHOSPHOCREATINE; PREDICTIVE VALUE OF TESTS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; REFERENCE VALUES; STEREOTAXIC TECHNIQUES;

EID: 33746233487     PISSN: 14389029     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-926744     Document Type: Article

References (21)

1. Preul MC, Caramanos Z, Leblanc R et al. Using pattern analysis of in vivo proton MRSI data to improve the diagnosis and surgical management of patients with brain tumors. NMR Biomed 1998; 11: 192-200
2. Graves EE, Pirzkall A, Nelson SJ et al. Registration of magnetic resonance spectroscopic imaging to computed tomography for radiotherapy treatment planning. Med Phys 2001; 28: 2489-2496
3. Pirzkall A, McKnight TR, Graves EE et al. MR-spectroscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys 2001; 15: 915-928
4. Pirzkall A, Li X, Oh J et al. 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI. Int J Radiat Oncol Biol Phys 2004; 59: 126-137
5. Herfarth KK, Gutwein S, Debus J. Postoperative Radiotherapy of Astrocytomas. Semin Surg Oncol 2001; 20: 13-23
6. Plathow C, Schulz-Ertner D, Thilman C et al. Fractionated stereotactic radiotherapy in low-grade astrocytomas: long-term outcome and prognostic factors. Int J Radiat Oncol Biol Phys 2003; 57: 996-1003
7. Graves EE, Nelson SJ, Vigneron DB et al. Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery. AJNR Am J Neuroradiol 2001; 22: 613-624
8. Träber F, Block W, Flacke S et al. 1H-MR-Spektroskopie von Hirntumoren im Verlauf der Strahlentherapie: Anwendung von schneller spektroskopischer Bildgebung und Einzelvolumen-MRS in der Rezidivdiagnostik. Fortschr Röntgenstr 2002; 174: 33-42
9. Lichy MP, Bachert P, Henze M et al. Monitoring individual response to brain-tumour chemotherapy: proton MR spectroscopy in a patient with recurrent glioma after stereotactic radiotherapy. Neuroradiology 2004; 46: 126-129
10. Plathow C, Lichy MP, Bachert P et al. The role of MRI in patients with astrocytoma WHO II treated with fractionated stereotactic radiotherapy. Eur Radiol 2004; 14: 679-685
11. Schlemmer HP, Bachert P, Herfarth KK et al. Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy. AJNR Am J Neuroradiol 2001; 22: 1316-1324
12. Lichy MP, Henze M, Plathow C et al. Metabolische Bildgebung zur Verlaufskontrolle stereotaktisch bestrahlter Gliome - Wertigkeit der 1H-MR Spektroskopie im Vergleich zur FDG-PET und IMT-SPECT. Fortschr Röntgenstr 2004; 176: 1106-1113
13. Rabinov JD, Lee PL, Barker FG et al. In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience. Radiology 2002; 225: 871-879
14. Nafe R, Herminghaus S, Raab P et al. Preoperative proton-MR spectroscopy of gliomas - correlation with quantitative nuclear morphology in surgical specimen. J Neurooncol 2003; 63: 233-245
15. Schuff N, Ezekiel F, Gamst AC et al. Region and Tissue Differences of Metabolites in Normally Aged Brain Using Multislice 1H Magnetic Resonance Spectroscopic Imaging. Magn Reson Med 2001; 45: 899-907
16. Soher BJ, Young K, Govindaraju V et al. Automated spectral analysis III: Application to in vivo proton MR spectroscopy and spectroscopic imaging. Magn Reson Med 1998; 40: 822-831
17. Rutkowski T, Tarnawski R, Sokol M et al. 1H-MR spectroscopy of normal brain tissue before and after postoperative radiotherapy because of primary brain tumors. Int J Radiat Oncol Biol Phys 2003; 56: 1381-1389
18. Law M, Yang S, Wang H et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003; 24: 1989-1998
19. Murphy PS, Viviers L, Abson C et al. Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy. Br J Cancer 2004; 90: 781-786
20. Kuznetsov YE, Caramanos Z, Antel SB et al. Proton magnetic resonance spectroscopic imaging can predict length of survival in patients with supratentorial gliomas. Neurosurgery 2003; 53: 565-574; discussion 574-576
21. Hunjan S, Adalsteinsson E, Kim DH et al. Quality assurance of magnetic resonance spectroscopic imaging-derived metabolic data. Int J Radiat Oncol Biol Phys 2003; 57: 1159-1173